EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Chronotherapeutic Effects of Atorvastatin Administration on Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial

Sepideh Tavanaei Fard, Zoleika Moazezi, Akramasadat Hosseini, Hoda Shirafkan, Ali Nosrati Andevari, Neda Meftah

Advances in Pharmacology and Therapeutics Journal · 16.06.2026

DOI: 10.18502/aptj.v5i4.21762 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Advances in Pharmacology and Therapeutics Journal, online erschienen am 16.06.2026. Verfasst von Sepideh Tavanaei Fard und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2DM) is commonly associated with dyslipidemia and increased cardiovascular risk. Atorvastatin, a widely used statin, effectively improves lipid profiles. This study aimed to compare the effects of morning versus evening administration of atorvastatin on lipid parameters in patients with T2DM. Materials and Methods: This randomized controlled trial enrolled 76 patients with T2DM, randomly assigned to receive Atorvastatin 40 mg either in the morning (n=38) or evening (n=38) for 4 weeks. Fasting serum triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured at baseline and post-treatment. Baseline lipid values were included as covariates in ANCOVA to compare post-treatment levels between groups.

Results

Atorvastatin significantly improved lipid profiles in both groups: LDL-C, TG, and TC decreased (P

Zitieren

APA

Fard, S. T., Moazezi, Z., Hosseini, A., Shirafkan, H., Andevari, A. N., & Meftah, N. (2026). Chronotherapeutic Effects of Atorvastatin Administration on Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial. Advances in Pharmacology and Therapeutics Journal. https://doi.org/10.18502/aptj.v5i4.21762

Vancouver

Fard ST, Moazezi Z, Hosseini A, Shirafkan H, Andevari AN, Meftah N. Chronotherapeutic Effects of Atorvastatin Administration on Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial. Advances in Pharmacology and Therapeutics Journal. 2026. doi:10.18502/aptj.v5i4.21762

BibTeX
@article{Fard2026,
  author = {Fard, Sepideh Tavanaei and Moazezi, Zoleika and Hosseini, Akramasadat and Shirafkan, Hoda and Andevari, Ali Nosrati and Meftah, Neda},
  title = {Chronotherapeutic Effects of Atorvastatin Administration on Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial},
  journal = {Advances in Pharmacology and Therapeutics Journal},
  year = {2026},
  doi = {10.18502/aptj.v5i4.21762}
}
Kostenlos starten →